Stockscreener 앱 받기
36.81
0.88%
0.32
시장 영업 전:
36.96
0.15
+0.41%
전일 마감가:
$36.49
열려 있는:
$36.58
하루 거래량:
482.36K
Relative Volume:
0.82
시가총액:
$1.87B
수익:
$276.26M
순이익/손실:
$16.52M
주가수익비율:
119.59
EPS:
0.3078
순현금흐름:
$24.75M
1주 성능:
+3.25%
1개월 성능:
+7.82%
6개월 성능:
-1.05%
1년 성능:
-6.24%
1일 변동 폭
$35.95
$37.17
1주일 범위
$33.10
$37.17
52주 변동 폭
$28.95
$45.97
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
36.81 | 1.87B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight - GlobeNewswire Inc.
MSN Money - MSN
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity - ChartMill
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet - Yahoo Finance
Vericel (VCEL) director receives new RSU and stock option grants - Stock Titan
Vericel (NASDAQ: VCEL) director awarded RSUs and 8,000 stock options - Stock Titan
Vericel (NASDAQ: VCEL) director logs RSU conversion and new 8,000-share option grant - Stock Titan
Vericel (VCEL) director defers RSUs and receives new option grant - Stock Titan
Vericel (VCEL) director reports RSU vesting and new stock option awards - Stock Titan
Vericel (VCEL) investors back board slate, executive pay and PwC as auditor - Stock Titan
Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor - Yahoo Finance
Vanguard buys/holds 2.60M Vericel shares — Vericel (NASDAQ: VCEL) - Stock Titan
Vericel (VCEL) Expected to Announce Earnings on Thursday - MarketBeat
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vericel sets May 7 earnings call, with webcast replay through 2027 - Stock Titan
Vericel (NASDAQ:VCEL) Shares Down 7.1%Time to Sell? - MarketBeat
VCEL Forecast, Price Target & Analyst Ratings | VERICEL CORP (NASDAQ:VCEL) - ChartMill
VCEL Maintains Buy Rating -- Price Target Lowered to $42 by Trui - GuruFocus
Truist Cuts Price Target on Vericel to $42 From $48, Keeps Buy Rating - marketscreener.com
Vericel Corporation (VCEL) secures FDA approval for commercial manufacturing of MACI - MSN
Vericel Corporation (VCEL) Stock Price, News, Quote & History - Yahoo Finance
Critical Limb Ischemia Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Baxter, Ixaka, Hemostemix Inc., Caladrius Biosciences, Vericel Corporation, Helixmith, Lifecells, LLC - Barchart
Assessing Vericel (VCEL) Valuation After BARDA Awards Up To US$197 Million NexoBrid Contract - simplywall.st
Q3 2025 Vericel Corp Earnings Call Transcript - GuruFocus
Is Vericel Corporation (VCEL) Stock Trending Up | Price at $33.41, Down 1.82%Community Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai
Winners Losers: What are the future prospects of Vericel Corporation2026 Major Catalysts & Smart Swing Trading Techniques - baoquankhu1.vn
Weekly Trades: Is Vericel Corporation part of any ETF2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn
Jonathan Mark Hopper Sells 3,472 Shares of Vericel (NASDAQ:VCEL) Stock - MarketBeat
Vericel (VCEL) CMO sells 3,472 shares after option exercise under 10b5-1 plan - Stock Titan
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines - Cantech Letter
After islet transplants, 10 diabetes patients stopped using insulin - Stock Titan
Aberdeen Group plc Has $21.03 Million Stock Position in Vericel Corporation $VCEL - MarketBeat
Analysts Set Vericel Corporation (NASDAQ:VCEL) Price Target at $56.00 - Defense World
Vericel Corporation (VCEL) Stock forecasts - Yahoo Finance UK
VCEL SEC FilingsVericel 10-K, 10-Q, 8-K Forms - Stock Titan
Allspring Global Investments Holdings LLC Cuts Position in Vericel Corporation $VCEL - marketbeat.com
Vericel Corporation (VCEL) Stock Forecasts - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
VCEL Stock Analysis: Vericel Corporation 4.85% gain, 34.14 performance outlook - Newser
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com India
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Vericel (VCEL) Secures Lucrative Contract with Health and Human Services - GuruFocus
U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
U.S. burn emergency stockpile gets NexoBrid in $197M BARDA pact - Stock Titan
[144] Vericel Corp SEC Filing - Stock Titan
Soleus discloses 2.55M Vericel shares (NASDAQ: VCEL) - Stock Titan
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart - Capital.com
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Quarterly Trades: Is Vericel Corporation in a bullish channel2026 Market Mood & Free Verified High Yield Trade Plans - baoquankhu1.vn
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):